Cempra (CEMP:NAS) and Trillium Therapeutics (TRIL:NAS) Trading at Less than Cash Value

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
CZR Caesars Entertainment Corp 9.550000 147184937 None None 10.28 -36.18
YTRA Yatra Online Inc 9.500000 33809313 None 7.3320 85.15 83.68
CEMP Cempra Inc 3.750000 52392905 None 1.0716 4.42 4.13
AMCN AirMedia Group Inc 2.750000 62197822 None 0.4816 3.52 1.40
PCO Pendrell Corp 6.500000 24640244 10.1563 0.7936 7.09 8.67
OPHT Ophthotech Corp 3.660000 35808442 None None 3.74 5.88
ADVM Adverum Biotechnologies Inc 2.700000 42063237 None 0.5268 5.28 1.20
TRIL Trillium Therapeutics Inc 6.150000 7845184 None 2.4715 6.43 6.41
ZAIS ZAIS Group Holdings Inc 2.700000 14649840 None 0.8913 5.17 -21.19
OREX Orexigen Therapeutics Inc 3.440000 11246673 None 0.6782 8.22 -6.55
APWC Asia Pacific Wire & Cable Corp Ltd 2.750000 13819669 12.5000 0.2635 3.09 0.44
GIGM GigaMedia Ltd 3.070000 11052235 None 0.5389 6.13 5.90
BEBE bebe stores Inc 3.930000 8066805 None 0.2738 8.28 11.33
ATEC Alphatec Holdings Inc 2.330000 10829625 None None 2.36 -1.41
ONTX Onconova Therapeutics Inc 3.040000 6759895 None 4.7824 3.17 None
ABAC Aoxin Tianli Group Inc 2.300000 7988245 19.1667 0.2184 6.82 6.49
GLBR Global Brokerage Inc 2.700000 6143305 0.1566 None 140.45 114.18
CYCC Cyclacel Pharmaceuticals Inc 3.680000 4251229 None 0.9235 4.24 2.70
TEAR TearLab Corp 2.840000 5367156 None None 2.88 -2.05
VISN.DL VisionChina Media Inc 2.240000 5137098 None 0.3599 2.92 -10.13
KBSF KBS Fashion Group Ltd 5.550000 1767911 None 0.0985 14.63 13.73
CBIO Catalyst Biosciences Inc 9.430000 1000036 2.4222 0.5868 10.26 -9.14
ROSG Rosetta Genomics Ltd 2.940000 1868121 None 1.2434 3.30 1.27
CLNT Cleantech Solutions International Inc 2.870000 1309121 None 0.0485 9.10 6.72
MDGS Medigus Ltd 3.080000 882857 None 0.6683 4.38 None

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

CEMP:NAS Cempra

http://www.cempra.com
Cempra has 45 employees and is headquartered in United States.
Cempra Inc is a clinical-stage pharmaceutical company. It develops antibiotics for acute care & community settings to meet critical medical needs in treatment of bacterial infectious diseases, respiratory tract & chronic staphylococcal infections.

TRIL:NAS Trillium Therapeutics

http://www.trilliumtherapeutics.com
Trillium Therapeutics has 47 employees and is headquartered in Canada.
Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.